Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat.

Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...

In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...

A new Brazilian study has revealed the key role of the protein periostin and stellate pancreatic cells in allowing pancreatic ...

More Americans are living with cancer as death rates continue to decline, thanks to improved detection methods and better ...

In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...

The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

A new study explains how pancreatic tumors use a sugar coating to hide from the immune system and shows that a newly ...

A new tool to classify pancreatic cancer subtypes will help clinicians and researchers overcome the challenges posed by the ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...